Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

13.3%

2 terminated/withdrawn out of 15 trials

Success Rate

84.6%

-1.9% vs industry average

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 2

2(20.0%)

Phase 4

1(10.0%)

Phase 1

1(10.0%)

Phase 3

1(10.0%)

10Total

N/A(5)

Phase 2(2)

Phase 4(1)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT06827795Not ApplicableRecruiting

An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)

Role: collaborator

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT01745588Phase 2Completed

Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma

Role: collaborator

NCT04906252Completed

Vfib by ECG or Echo During Cardiac Arrest

Role: collaborator

NCT03881176Not ApplicableCompleted

PoNS Clinical Experience Program in Traumatic Brain Injury Patients (TBI)

Role: collaborator

NCT02534987Not ApplicableCompleted

Integrated Clinical Prediction Rules: Bringing Evidence to Diverse Primary Care Settings

Role: collaborator

NCT00225758Phase 2Terminated

Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy